← Back to Screener
Belite Bio, Inc American Depositary Shares (BLTE)
Price$158.05
Favorite Metrics
Price vs S&P 500 (26W)112.21%
Price vs S&P 500 (4W)-1.22%
Market Capitalization$6.87B
All Metrics
Book Value / Share (Quarterly)$4.55
P/TBV (Annual)13.25x
Indicated Dividend (Annual)$0.00
Price vs S&P 500 (YTD)2.86%
EPS (TTM)$-1.55
10-Day Avg Trading Volume0.16M
EPS Excl Extra (TTM)$-1.55
EPS (Annual)$-1.18
ROI (Annual)-24.79%
Cash / Share (Quarterly)$4.56
ROA (Last FY)-23.76%
EBITD / Share (TTM)$-1.56
ROE (5Y Avg)-34.27%
Cash Flow / Share (Annual)$-0.92
P/B Ratio47.16x
P/B Ratio (Quarterly)17.72x
Net Income / Employee (Annual)$-1
Net Interest Coverage (TTM)-574.00x
ROA (TTM)-31.55%
EPS Incl Extra (Annual)$-1.18
Current Ratio (Annual)24.31x
Quick Ratio (Quarterly)24.09x
3-Month Avg Trading Volume0.21M
52-Week Price Return187.94%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$4.58
52-Week High$200.00
EPS Excl Extra (Annual)$-1.18
26-Week Price Return116.19%
Quick Ratio (Annual)24.09x
13-Week Price Return9.03%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)24.31x
Enterprise Value$6,871.236
Revenue / Employee (Annual)$0
Cash / Share (Annual)$4.56
3-Month Return Std Dev47.37%
Net Income / Employee (TTM)$-2
ROE (Last FY)-24.79%
EPS Basic Excl Extra (Annual)$-1.18
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-1.55
ROI (TTM)-32.86%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$4.58
Price vs S&P 500 (52W)158.11%
Year-to-Date Return5.50%
5-Day Price Return-6.85%
EPS Normalized (Annual)$-1.18
ROA (5Y Avg)-32.16%
Month-to-Date Return5.85%
EBITD / Share (Annual)$-1.30
ROI (5Y Avg)-34.21%
EPS Basic Excl Extra (TTM)$-1.55
P/TBV (Quarterly)13.25x
P/B Ratio (Annual)13.25x
Book Value / Share (Annual)$4.58
Price vs S&P 500 (13W)8.34%
Beta-1.16x
Revenue / Share (TTM)$0.00
ROE (TTM)-32.86%
52-Week Low$53.59
Industry Peers — Pharmaceuticals(309)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
BLTEBelite Bio, Inc American Depositary Shares | — | — | — | — | $158.05 |
LLYEli Lilly & Co. | 13.08x | 44.70% | 83.04% | 27.59% | $903.99 |
JNJJohnson & Johnson | 5.94x | 7.87% | 67.95% | 14.90% | $234.54 |
ABBVABBVIE INC. | 6.04x | 8.57% | 71.62% | -2.88% | $208.99 |
MRKMerck & Co., Inc. | 4.41x | 1.31% | 78.55% | 21.23% | $115.46 |
AZNAstraZeneca PLC | 5.28x | 8.63% | 81.31% | 21.88% | $200.47 |
NVSNovartis AG | 4.98x | 8.91% | 75.82% | 15.26% | $149.73 |
NVONovo-Nordisk A/S | 3.62x | 6.43% | 80.98% | 20.66% | $40.93 |
ABTAbbott Laboratories | 3.66x | 6.59% | 56.50% | 8.20% | $95.47 |
PFEPfizer Inc. | 2.47x | -1.64% | 75.81% | -3.51% | $27.22 |
BMYBristol-Myers Squibb Co. | 2.47x | -0.22% | 72.63% | — | $58.96 |
About
Belite Bio is a clinical-stage biopharmaceutical company developing novel therapeutics for retinal degeneration and metabolic diseases. Its pipeline includes treatments for age-related macular degeneration, Stargardt disease, nonalcoholic fatty liver disease, type 2 diabetes, and gout.